A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
13h
IFLScience on MSNNew mRNA Vaccine Against World's Biggest Infectious Killer Shows PromiseA new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...
The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition ...
15h
News Medical on MSNVimseltinib gains FDA approval for treating tenosynovial giant cell tumorThe U.S. Food and Drug Administration (FDA) has approved vimseltinib (RomvimzaTM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results